8-K ACP-104 PHASE IIB TRIAL

Company

ACADIA PHARMACEUTICALS INC

Filed

June 16, 2008

Period of Report

June 16, 2008

Accession Number

0001181431-08-038774

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →